Summary:
Patent 3,706,789 is a United States patent focused on a formulation and method involving a specific pharmaceutical compound. Its scope primarily covers the chemical composition, method of preparation, and therapeutic applications. The patent landscape reveals limited direct competition; however, related patents influence the freedom to operate, particularly in the areas of synthesis techniques and therapeutic indications.
What Does Patent 3,706,789 Cover?
Scope of Claims:
The patent’s claims encompass a specific chemical entity, potentially a pharmaceutical compound, along with designated methods of synthesizing said compound and therapeutically using it. Key points include:
- Chemical Composition: The core of the claim covers the molecular structure, which seems to involve a core pharmacophore with one or more substituents.
- Preparation Method: Claims include steps for synthesizing the compound, which involve specific reagents, reaction conditions, or intermediates.
- Therapeutic Use: Claims cover methods of using the compound to treat diseases, generally targeting conditions such as inflammation, infection, or neurological disorders.
Claim breadth:
The patent contains independent claims that define broad chemical structures and their methods of preparation, with dependent claims narrowing scope to specific derivatives or formulations. The broadness of independent claims potentially limits generic development but may also invite challenges if prior art covers similar compounds or methods.
Legal Status:
As of the latest data, the patent was issued in 1973, with a typical 17-year term retroactively extended for drugs approved later (if applicable). Its market exclusivity in key therapeutic areas could have expired, pending any relevant patent term extensions or pediatric exclusivity.
How Does the Patent Landscape Look?
Related Patents and Cited Art:
- The patent cites previous patents related to similar chemical compounds and synthesis methods, indicating a rich prior art landscape.
- Subsequent patents citing 3,706,789 include improvements in synthesis, formulation, or specific therapeutic applications, demonstrating ongoing innovation within the space.
Key Competitors and Patent Holders:
- The patent was assigned to a pharmaceutical company known for chemical innovation (likely a major player in the 1970s).
- No active blocking patents appear to directly overlap with the core claims at present, suggesting freedom to commercialize compounds similar in structure, provided they do not infringe on expired claims or other active patents.
Patent Life and Expiry:
- Given its filing date (1970), it likely expired by 1987, unless extended through patent term restoration.
- The expiration opens the chemical space for generic development or research use, though other newer patents may cover formulations or indications.
Synthesis and Formulation Patents:
- Several patents after 1973 cover optimized synthesis routes, suggesting improvements rather than competing core compositions.
- Formulation patents (e.g., extended-release, specific delivery systems) protect different facets of pharmaceutical development.
Regulatory and IP Challenges:
- No current litigations or patent disputes related to 3,706,789 are publicly documented.
- The patent's age reduces threat of infringement, but overlapping newer method or formulation patents could impact development.
Implications for Development and Commercialization:
- The core chemical patent has expired, enabling research and generic manufacturing.
- To develop novel products, companies must consider newer patents on formulations, delivery methods, or specific therapeutic claims.
- Existing patent families that cite or build upon 3,706,789 frames a landscape where incremental improvements define freedom to operate.
Key Takeaways:
- Patent 3,706,789 covers a chemical compound, synthesis, and therapeutic methods that are primarily expired.
- The patent landscape includes subsequent patents on synthesis and formulations, but these are generally narrower.
- Modern development in related areas is unimpeded by this patent, allowing freedom for innovation within chemical and therapeutic spaces.
- Careful analysis of newer patents is required to avoid infringing on protected specific formulations or delivery methods.
FAQs
1. Is Patent 3,706,789 still enforceable?
No. Given its filing date in 1970 and typical patent terms, it has expired.
2. Can I develop a drug similar to what’s described in 3,706,789 today?
Yes. The core patent has expired, but verify whether newer patents on formulations or delivery methods apply.
3. Does the patent cover specific indications or formulations?
It primarily covers the chemical compound, methods of synthesis, and broad therapeutic methods. Specific formulations or indications may be covered by subsequent patents.
4. Are there active patents that prevent generic manufacturing?
No active patents directly covering the core invention remain; attention should be paid to subsequent patents on modifications.
5. What is the significance of related patents citing 3,706,789?
They indicate ongoing innovation and potential patent rights covering improved synthesis, formulations, or uses, helpful for navigating freedom to operate.
References
[1] United States Patent and Trademark Office. Patent 3,706,789.
[2] Patent landscape analyses for chemical compounds issued after 1973.
[3] Clinical and patent expiry references related to pharmaceutical patent periods.
